BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10206522)

  • 1. Childhood medulloblastoma: progress and future challenges.
    Packer RJ
    Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma: clinical and biologic aspects.
    Packer RJ; Cogen P; Vezina G; Rorke LB
    Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma: presentation, diagnosis and management.
    Packer RJ; Finlay JL
    Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
    Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
    World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current multimodality management of medulloblastoma.
    Paulino AC
    Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of the prognostic factors in medulloblastoma of children and adults.
    Brandes AA; Paris MK
    Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the management of pediatric and adult medulloblastoma].
    Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
    Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tumors: Medulloblastoma, ATRT, ependymoma.
    Baliga S; Gandola L; Timmermann B; Gail H; Padovani L; Janssens GO; Yock TI
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28395. PubMed ID: 32386126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
    Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
    J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastomas and central nervous system primitive neuroectodermal tumors.
    McLean TW
    Curr Treat Options Oncol; 2003 Dec; 4(6):499-508. PubMed ID: 14585230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment controversies in medulloblastoma.
    Chintagumpala M; Berg S; Blaney SM
    Curr Opin Oncol; 2001 May; 13(3):154-9. PubMed ID: 11307057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastomas.
    Sutton LN; Packer RJ; Schut L
    Neurosurg Clin N Am; 1990 Jan; 1(1):97-109. PubMed ID: 2135976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.
    Reddick WE; Russell JM; Glass JO; Xiong X; Mulhern RK; Langston JW; Merchant TE; Kun LE; Gajjar A
    Magn Reson Imaging; 2000 Sep; 18(7):787-93. PubMed ID: 11027871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment of medulloblastoma: recent advances and future challenges.
    Rood BR; Macdonald TJ; Packer RJ
    Semin Oncol; 2004 Oct; 31(5):666-75. PubMed ID: 15497120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood medulloblastoma.
    Walker RW; Rosenblum MK
    Rev Neurol (Paris); 1992; 148(6-7):467-76. PubMed ID: 1448667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellopontine angle medulloblastoma.
    Nyanaveelan M; Azmi A; Saffari M; Banu SK; Suryati MY; Jeyaledchumy M
    Med J Malaysia; 2007 Jun; 62(2):173-4. PubMed ID: 18705459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
    J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.